203 related articles for article (PubMed ID: 9250551)
1. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
[TBL] [Abstract][Full Text] [Related]
2. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
[TBL] [Abstract][Full Text] [Related]
3. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
[TBL] [Abstract][Full Text] [Related]
4. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
[TBL] [Abstract][Full Text] [Related]
5. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
[TBL] [Abstract][Full Text] [Related]
6. [Demonstration of the fibrillatory effect of class I anti-arrhythmia agents based on the time of fibrillation onset and electrical threshold in myocardial ischemia].
Timour Q; Aupetit JF; Loufoua-Moundanga JL; Barral-Cadière L; Freysz M; Faucon G
Therapie; 1994; 49(4):349-53. PubMed ID: 7878603
[TBL] [Abstract][Full Text] [Related]
7. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.
Aupetit JF; Freysz M; Faucon G; Loufoua-Moundanga J; Coquelin H; Timour Q
Acta Anaesthesiol Scand; 1997 Apr; 41(4):516-23. PubMed ID: 9150782
[TBL] [Abstract][Full Text] [Related]
8. Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes.
Timour Q; Aupetit JF; Freysz M; Frassati D; Faucon G
Can J Physiol Pharmacol; 1996 Dec; 74(12):1308-14. PubMed ID: 9047040
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation].
Aupetit JF; Timour Q; Chevrel G; Omar S; Loufoua-Moundanga J; Faucon G
Therapie; 1993; 48(4):403-7. PubMed ID: 8128424
[TBL] [Abstract][Full Text] [Related]
10. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study.
Vaillant F; Timour Q; Descotes J; Manati W; Belhani D; Bui-Xuan B; Tabib A; Bricca G; Chevalier P
J Cardiovasc Pharmacol; 2008 Dec; 52(6):548-54. PubMed ID: 19034029
[TBL] [Abstract][Full Text] [Related]
11. [Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].
Faucon G; Aupetit JF; Gerentes-Chassagne I; Loufoua-Moundanga J; Larbre JP; Timour Q
Bull Acad Natl Med; 1991 Feb; 175(2):217-24; discussion 224-5. PubMed ID: 1907520
[TBL] [Abstract][Full Text] [Related]
12. Proarrhythmic actions of flecainide in an isolated tissue model of ischemia and reperfusion.
Heisler BE; Ferrier GR
J Pharmacol Exp Ther; 1996 Oct; 279(1):317-24. PubMed ID: 8859009
[TBL] [Abstract][Full Text] [Related]
13. Effects of diltiazem upon experimental ventricular dysrhythmias.
Patterson E; Eller BT; Lucchesi BR
J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274
[TBL] [Abstract][Full Text] [Related]
14. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
Billman GE; Hamlin RL
J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.
Timour Q; Larbre JP; Kioueh I; Aupetit JF; Loufoua-Moundanga J; Vialle A; Faucon G
Arch Int Pharmacodyn Ther; 1992; 315():30-46. PubMed ID: 1384452
[TBL] [Abstract][Full Text] [Related]
16. Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
Aupetit JF; Timour Q; Larbre JP; Loufoua-Moundanga J; Kioueh I; Lopez M; Faucon G
Cardiovasc Drugs Ther; 1993 Apr; 7(2):217-23. PubMed ID: 8357775
[TBL] [Abstract][Full Text] [Related]
17. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy].
Gülker H; Thale J
Z Kardiol; 1986; 75 Suppl 5():15-34. PubMed ID: 3825228
[TBL] [Abstract][Full Text] [Related]
18. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
Nakaya H
Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
[TBL] [Abstract][Full Text] [Related]
19. Study of the ventricular antifibrillatory effects of calcium channel blocking agents in comparison with lidocaine on canine normal heart in situ.
Chah QT; Bertrix L; Bouzouita K; Lang J; Faucon G
Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):238-48. PubMed ID: 6838283
[TBL] [Abstract][Full Text] [Related]
20. The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy.
Rivard L; Sinno H; Shiroshita-Takeshita A; Schram G; Leung TK; Nattel S
Cardiovasc Res; 2007 Apr; 74(1):104-13. PubMed ID: 17316585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]